VORVor Biopharma Inc.

23.36USD-0.93%Mkt Cap: 1.27B $P/E: 0.13

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treat…